Norma Drug Discovery With Quantum AI Algorithms On CUDA-Q
Quantum AI Algorithms Norma Speeds Drug Discovery on NVIDIA CUDA-Q with Quantum AI
Leading quantum computing startup Norma has validated its quantum AI algorithms on the NVIDIA CUDA-Q platform, which computes up to 73 times quicker, achieving a drug discovery breakthrough. Running Norma's algorithms on NVIDIA GH200 Grace Hopper Superchips enabled this vital achievement, which advances quantum AI's ability to solve complex scientific problems. Under CEO Hyunchul Jung, the company has successfully demonstrated how quantum AI can be applied in drug development and plans to validate these efforts in other industries. Revolutionising Drug Discovery with Quantum AI The vast chemical search space often creates computational hurdles in the quest for new medicinal options. Traditional AI systems' limitations in this vast sector slow medication development. Norma's Quantum AI team pioneered quantum AI methods to overcome these difficulties. QLSTM, QGAN, and QCBM boost computer power for drug candidate discovery. A combined research study with Kyung Hee University Hospital in Gangdong focused on novel medicine candidates, including the validation trial. Norma is developing quantum AI algorithms for biotechnology, banking, and defence. Quantum-Classical Hybrid Operations Accelerator NVIDIA CUDA-Q The NVIDIA CUDA-Q platform accelerated Norma's quantum algorithm creation and implementation, contributing to their success. CUDA-Q simplifies GPU and QPU integration for quantum-classical hybrid processes. This expertise is needed to execute complex quantum AI algorithms. Norma employed CUDA-Q and NVIDIA H200 GPUs and GH200 Grace Hopper Superchips for validation testing. CUDA-Q testing of these algorithms is underway by the company.
Massive Performance Improvements: Metrics The performance validation demonstrated that NVIDIA CUDA-Q outperforms CPU-based methods. The execution and measurement (forward propagation) speeds of an 18-qubit quantum circuit were 60.14 to 73.32 times quicker than CPU-based quantum simulators. The loss function-based backward propagation correction process also accelerated by 33.69 to 41.56 times. Comparing the GH200 Grace Hopper Superchips with NVIDIA H200 GPUs showed NVIDIA's latest hardware's effectiveness. The GH200 processed faster than the H200 with 22% faster forward and 24% faster back propagation. These data demonstrate how Norma's quantum AI and NVIDIA's cutting-edge platforms improved computing efficiency. Cutting costs and boosting innovation Beyond its quickness, this endeavour is highly useful. By enabling fast and realistic algorithm verification before quantum hardware implementation, Norma has greatly reduced development time and expense. This faster verification procedure increases optimisation potential, enabling more advanced and effective quantum AI models. The validation shows that quantum AI technology may be used in real-world settings, including drug discovery, and provides vital data for the future deployment of quantum hardware in many sectors. Vision for Future Collaboration and Growth Norma CEO Hyunchul Jung praised the collaboration and future potential. “This project is a meaningful example of collaboration between domestic and international quantum technology companies and hospitals, demonstrating quantum technology's practical potential,” he said. Norma is committed to future growth. Jung added, “Through active technological cooperation with NVIDIA, it plans to continuously expand performance testing of quantum AI algorithms across a wide range of sectors, like healthcare.” The company is ready to validate quantum AI in other areas after acquiring the initial drug development use cases. Conclusion The approval of Norma's quantum AI algorithms on the NVIDIA CUDA-Q platform marked a turning point in artificial intelligence and quantum computing. The reported 73x speedup in medicine development dramatically reduces computational restrictions that have inhibited innovative therapy development. This invention sets a precedent for quantum AI's transformative potential in other complex domains and shows its immediate utility in a high-impact business like healthcare. As Norma and NVIDIA continue their relationship, quantum AI will grow faster, bringing the era of viable quantum solutions closer.